Gilead Sciences, Inc. vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
8.1
Buy
Overall
6.5
Hold
Quality
Health
Growth
Valuation
Sentiment
GILD
High-quality business with 41% return on equity and 29% profit margins.
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $158.36 (+19.9%)
28 analysts
HOLD
Target $29.00 (+8.3%)
27 analysts
Fundamentals
GILD
PFE
19.5×
Trailing P/E
19.7×
13.7×
Forward P/E
9.5×
28.9%
Profit Margin
12.4%
78.8%
Gross Margin
75.8%
40.7%
ROE
8.9%
4.7%
Revenue Growth
-1.2%
23.4%
Earnings Growth
—
0.40
Beta
0.39
—
Price / Book
—
$163.9B
Market Cap
$152.3B
$95 – $157
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.